119 related articles for article (PubMed ID: 5188)
1. The metabolic activation of the carcinogen 1'-hydroxysafrole in vivo and in vitro and the electrophilic reactivities of possible ultimate carcinogens.
Wislocki PG; Borchert P; Miller JA; Miller EC
Cancer Res; 1976 May; 36(5):1686-95. PubMed ID: 5188
[TBL] [Abstract][Full Text] [Related]
2. N2 atom of guanine and N6 atom of adenine residues as sites for covalent binding of metabolically activated 1'-hydroxysafrole to mouse liver DNA in vivo.
Phillips DH; Miller JA; Miller EC; Adams B
Cancer Res; 1981 Jul; 41(7):2664-71. PubMed ID: 7248936
[TBL] [Abstract][Full Text] [Related]
3. Strong evidence from studies with brachymorphic mice and pentachlorophenol that 1'-sulfoöxysafrole is the major ultimate electrophilic and carcinogenic metabolite of 1'-hydroxysafrole in mouse liver.
Boberg EW; Miller EC; Miller JA; Poland A; Liem A
Cancer Res; 1983 Nov; 43(11):5163-73. PubMed ID: 6577945
[TBL] [Abstract][Full Text] [Related]
4. Further characterization of the DNA adducts formed by electrophilic esters of the hepatocarcinogens 1'-hydroxysafrole and 1'-hydroxyestragole in vitro and in mouse liver in vivo, including new adducts at C-8 and N-7 of guanine residues.
Wiseman RW; Fennell TR; Miller JA; Miller EC
Cancer Res; 1985 Jul; 45(7):3096-105. PubMed ID: 4005847
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the biliary and urinary glutathione and N-acetylcysteine metabolites of the hepatic carcinogen 1'-hydroxysafrole and its 1'-oxo metabolite in rats and mice.
Fennell TR; Miller JA; Miller EC
Cancer Res; 1984 Aug; 44(8):3231-40. PubMed ID: 6744260
[TBL] [Abstract][Full Text] [Related]
6. The metabolic sulfonation and side-chain oxidation of 3'-hydroxyisosafrole in the mouse and its inactivity as a hepatocarcinogen relative to 1'-hydroxysafrole.
Boberg EW; Miller EC; Miller JA
Chem Biol Interact; 1986; 59(1):73-97. PubMed ID: 3757147
[TBL] [Abstract][Full Text] [Related]
7. The in vivo formation and repair of DNA adducts from 1'-hydroxysafrole.
Phillips DH; Hanawalt PC; Miller JA; Miller EC
J Supramol Struct Cell Biochem; 1981; 16(1):83-90. PubMed ID: 7299840
[TBL] [Abstract][Full Text] [Related]
8. Hepatic metabolism of N-hydroxy-N-methyl-4-aminoazobenzene and other N-hydroxy arylamines to reactive sulfuric acid esters.
Kadlubar FF; Miller JA; Miller EC
Cancer Res; 1976 Jul; 36(7 PT 1):2350-9. PubMed ID: 819129
[TBL] [Abstract][Full Text] [Related]
9. Sulfuric acid esters as ultimate electrophilic and carcinogenic metabolites of some alkenylbenzenes and aromatic amines in mouse liver.
Miller EC; Miller JA; Boberg EW; Delclos KB; Lai CC; Fennell TR; Wiseman RW; Liem A
Carcinog Compr Surv; 1985; 10():93-107. PubMed ID: 3904999
[No Abstract] [Full Text] [Related]
10. Metabolic activation of N-hydroxy-N,N'-diacetylbenzidine by hepatic sulfotransferase.
Morton KC; Beland FA; Evans FE; Fullerton NF; Kadlubar FF
Cancer Res; 1980 Mar; 40(3):751-7. PubMed ID: 6937241
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of the proximate carcinogen 1'-hydroxysafrole and the isomer 3'-hydroxyisosafrole.
Peele JD; Oswald EO
Bull Environ Contam Toxicol; 1978 Apr; 19(4):396-402. PubMed ID: 656641
[No Abstract] [Full Text] [Related]
12. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
13. The metabolism of the naturally occurring hepatocarcinogen safrole to 1'-hydroxysafrole and the electrophilic reactivity of 1'-acetoxysafrole.
Borchert P; Wislocki PG; Miller JA; Miller EC
Cancer Res; 1973 Mar; 33(3):575-89. PubMed ID: 4689905
[No Abstract] [Full Text] [Related]
14. Carcinogenic and mutagenic activities of safrole, 1'-hydroxysafrole, and some known or possible metabolites.
Wislocki PG; Miller EC; Miller JA; McCoy EC; Rosenkranz HS
Cancer Res; 1977 Jun; 37(6):1883-91. PubMed ID: 192464
[No Abstract] [Full Text] [Related]
15. 32P-post-labelling analysis of DNA adducts formed in the livers of animals treated with safrole, estragole and other naturally-occurring alkenylbenzenes. I. Adult female CD-1 mice.
Randerath K; Haglund RE; Phillips DH; Reddy MV
Carcinogenesis; 1984 Dec; 5(12):1613-22. PubMed ID: 6499112
[TBL] [Abstract][Full Text] [Related]
16. Major role of hepatic sulfotransferase activity in the metabolic activation, DNA adduct formation, and carcinogenicity of 1'-hydroxy-2',3'-dehydroestragole in infant male C57BL/6J x C3H/HeJ F1 mice.
Fennell TR; Wiseman RW; Miller JA; Miller EC
Cancer Res; 1985 Nov; 45(11 Pt 1):5310-20. PubMed ID: 3863702
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity studies of the carcinogenicities in the mouse and rat of some naturally occurring and synthetic alkenylbenzene derivatives related to safrole and estragole.
Miller EC; Swanson AB; Phillips DH; Fletcher TL; Liem A; Miller JA
Cancer Res; 1983 Mar; 43(3):1124-34. PubMed ID: 6825084
[TBL] [Abstract][Full Text] [Related]
18. Structures of hepatic nucleic acid-bound dyes in rats given the carcinogen N-methyl-4-aminoazobenzene.
Lin JK; Miller JA; Miller EC
Cancer Res; 1975 Mar; 35(3):844-50. PubMed ID: 1116139
[TBL] [Abstract][Full Text] [Related]
19. Microsomal N-oxidation of the hepatocarcinogen N-methyl-4-aminoazobenzene and the reactivity of N-hydroxy-N-methyl-4-aminoazobenzene.
Kadlubar FF; Miller JA; Miller EC
Cancer Res; 1976 Mar; 36(3):1196-1206. PubMed ID: 814998
[TBL] [Abstract][Full Text] [Related]
20. Differences in the covalent binding of benzo[a]pyrene, safrole, 1'-hydroxysafrole, and 4-aminobiphenyl to DNA of pregnant and non-pregnant mice.
Lu LJ; Disher RM; Randerath K
Cancer Lett; 1986 Apr; 31(1):43-52. PubMed ID: 3697953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
